- Home
- Companies
- canada saskatchewan
- intravitreal injection
Show results for
Refine by
Intravitreal Injection Suppliers Serving Saskatchewan
5 companies found
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
β-N-methylamino-L-alanine hydrochloride (BMAA hydrochloride) is a neurotoxin produced by cyanobacteria. β-N-methylamino-L-alanine hydrochloride activates mGluR3 and inhibits PKC. β-N-methylamino-L-alanine hydrochloride can be used in the research of ...
based inÇatalca, TURKEY
Meran Medical is a manufacturing company specializing in medical products with a focus on ophthalmic solutions. The company offers a range of products including cannulas for oculoplastic and vitreoretinal surgeries, ophthalmic surgical liquids, ...
This product is part of a broader range of ophthalmic surgical supplies, including cannulas, ophthalmic surgical liquids, and intravitreal injection kits, all designed to support successful surgical outcomes in ...
based inOakville, ONTARIO (CANADA)
We bring innovation and vision to practice globally through principled people. For over 60 years we’ve been world-wide leaders providing advanced eye care products, solutions, and resources for eye care professionals and their patients. Labtician ...
based inPARIS, FRANCE
FCI is a world leader in the development of a wide range of ophthalmic devices and is dedicated to providing physicians with innovative, high-performance and mostly exclusive products covering the fields of expertise of Oculoplasty, Dry Eye, Retina ...
Precivia is a disposable device that simplifies* intravitreal injections. Its special design ensures a fast, accurate & predictable ...
based inVancouver, BRITISH COLUMBIA (CANADA)
InMed Pharmaceuticals is a global leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, including clinical and preclinical programs targeting the treatment of diseases with high unmet ...